Psychopharmacology

, Volume 62, Issue 3, pp 301–305 | Cite as

Behavioral effects produced by long-term administration of a neuroleptic drug (flupenthixol) upon social interaction in a group of eight rats

  • A. Hecht
Original Investigations
Received:
Accepted:

Abstract

The behavioral effects produced by chronic treatment with α-flupenthixol decanoate followed by a 3-month pause upon social interaction in a group of eight rats were studied. α-Flupenthixol decanoate induced total disruption of two of the group formations studied, i.e., three or more in a group outside a corner and three or more following (running in a row) — the overall behavioral change shows a geneal depressive effect of the drug and a change in the pattern of social interaction. The shift in balance between the behavioral categories measured appeared as a significant difference in the time spent in the various group formations. Disintegration of group coherence, as shown in the measures of the degree of isolation, appeared only in the α-flupenthixol decanoate-treated group. An apomorphine test, which concluded the experiment 3 months after the last α-flupenthixol decanoate injection, revealed a significant difference in relation to licking response between the test group and the control group. The apomorphine test reported in this paper showed effects up to 90 days after the last drug treatment.

Key words

α-Flupenthixol decanoate Chronic treatment General depressive effect Disruption of the social interaction pattern Apomorphine test 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andén, N.-E., Rubinson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967)Google Scholar
  2. Burt, D. R., Snyder, S. H.: Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain. Science 196, 326–328 (1977)Google Scholar
  3. Christensen, A. V., Møller Nielsen, I.: Influence of flupenthixol and flupenthixol-decanoate on methylphenidate and apomorphine-induced gnawing in mice. Psychopharmacologia 34, 119–126 (1974)Google Scholar
  4. Christensen, A. V., Fjalland, B., Møller Nielsen, I.: On the super-sensitivity of dopamine receptors, induced by neuroleptics. Psychopharmacologia 48, 1–6 (1976)Google Scholar
  5. Cools, A., Janssen, H.-J.: The nucleus linearis intermedius raphe and behaviour evoked by direct and indirect stimulation of dopamine-sensitive sites within the caudate nucleus of cats. Eur. J. Pharmacol. 28, 266–275 (1974)Google Scholar
  6. Fjalland, B., Møller Nielsen, I.: Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptics. Psychopharmacologia 34, 105–109 (1974a)Google Scholar
  7. Fjalland, B., Møller Nielsen, I.: Methylphenidate antagonism of haloperidol interaction with cholinergic and anticholinergic drugs. Psychopharmacologia 34, 111–118 (1974b)Google Scholar
  8. Floru, L., Heinrich, K., Wittek, F.: The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Int. Pharmacopsychiatry 10, 230–239 (1975)Google Scholar
  9. Garattini, S., Bareggi, S., March, V., Calderini, G., Morsellini, P.: Effects of piripedil on noradrenaline and MOPEG-SO4 levels in rat brain. Eur. J. Pharmacol. 28, 214–216 (1974)Google Scholar
  10. Grabowska, M.: Influence of midbrain raphe lesion on some pharmacological and biochemical effects of apomorphine in rats. Psychopharmacologia 39, 315–322 (1974)Google Scholar
  11. Herz, A., Bläsig, J., Papeschi, R.: Role of catecholaminergic mechanisms in the expression of the morphine abstinence syndrome in rats. Psychopharmacologia 39, 121–143 (1974)Google Scholar
  12. Jørgensen, A., Fredricson, O. K., Hansen, V.: Metabolism, distribution and excretion of flupenthixol decanoate in dogs and rats. Acta Pharmacol. Toxicol. 29, 339–358 (1971)Google Scholar
  13. Klawans, H. L., Rubovits, R.: An experimental model of tardive dyskinesia. J. Neural. Transm. 33, 235–246 (1972)Google Scholar
  14. Moore, K. E., Thornburg, J. E.: Drug-induced dopaminergic supersensitivity. In: Advances in neurology, vol. 9, D. B. Calue, T. N. Chase, and A. Barbeau, eds., pp. 93–104. New York: Raven 1975Google Scholar
  15. Møller Nielsen, I., Hougs, W., Lassen, N., Holm, T., Petersen, P. V.: Central depressant activity of some thiaxanthene derivates. Acta Pharmacol. Toxicol. 19, 87–100 (1962)Google Scholar
  16. Møller Nielsen, I., Fjalland, B., Pedersen, V., Nymark, M.: Pharmacology of neuroleptics upon repeated administration Psychopharmacologia 34, 95–104 (1974)Google Scholar
  17. Nielsen, E. B.: Long-term behavioral and biochemical effects following prolonged treatment with a neuroleptic drug (flupenthixol) in rats. Psychopharmacology 54, 203–208 (1977)Google Scholar
  18. Nymark, M., Franck, K. F., Pedersen, V., Boeck, V., Møller Nielsen, I.: Prolonged neuroleptic effects of α-flupenthixol decanoate in oil. Acta Pharmacol. Toxicol. 33, 363–376 (1973)Google Scholar
  19. Persson, T., Waldeck, B.: Further studies on the possible interaction between dopamine- and noradrenaline-containing neurones in the brain. Eur. J. Pharmacol. 11, 315–320 (1970)Google Scholar
  20. Randrup, A., Munkvad, L.: Biochemical, anatomical and psychological investigations of stereotyped behavior induced by amphetamines. In: Symposium on amphetamines and related drugs, Milan, 1969, E. Costa and S. Garattini, eds., pp. 695–713. New York: Raven 1970Google Scholar
  21. Randrup, A., Munkvad, I.: Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Ortomolecular Psychiatry 1, 2–7 (1972a)Google Scholar
  22. Randrup, A., Munkvad, I.: Correlation between specific effects of amphetamines on the brain and on behaviour. In: Current concepts on amphetamine abuse, E. Ellinwood and S. Cohen, eds., pp. 17–25. Washington D. C.: U. S. Government Printing Office 1972bGoogle Scholar
  23. Randrup, A., Munkvad, I., Fog, R., Kjellberg, B., Lyon, M., Nielsen, E., Svennild, I., Schiørring, E.: Behavioural correlates to antipsychotic efficacy of neuroleptic drugs. In: Antipsychotic drugs, pharmacodynamics and pharmacokinetics, G. Sedvaal, B. Uvnäs and Y. Zotterman, eds., pp. 33–41. Oxford: Pergamon 1976Google Scholar
  24. Sayers, A. C., Bürki, H. R., Ruch, W., Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacologia 41, 1–16 (1975)Google Scholar
  25. Scheel-Krüger, J.: Central effects of anticholinergic drugs measured by the apomorphine gnawing in mice. Acta Pharmacol. Toxicol. 28, 1–16 (1970)Google Scholar
  26. Scheel-Krüger, J., Hasselager, E.: Studies of various amphetamines, apomorphine and clonidine on body temperature and brain 5-hydroxytryptamine metabolism in rats. Psychopharmacologia 36, 189–202 (1974)Google Scholar
  27. Scheel-Krüger, J.: Apomorphine-morphine. Biochemical and pharmacological aspects on the present status of knowledge with special considerations on the interaction of these two drugs. Considerations of the possible background for the clinical treatment of morphine addiction with apomorphine, pp. 93–121. Hambrug: Neue Autoren und Autographen Edition 1976Google Scholar
  28. Schiørring, E.: Amphetamine-induced selective stimulation of certain behaviour items with concurrent inhibition of others in an open-field test with rats. Behaviour 39, 1–17 (1971)Google Scholar
  29. Schiørring, E., Randrup, A.: Social isolation and changes in the formation of groups induced by amphetamine in an open-field test with rats. Pharmakopsykiatr. Neuro-Psychopharmakol. 4, 1–11 (1971)Google Scholar
  30. Tarsy, D., Baldessarini, R. J.: Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines. Neuropharmacology 13, 927–940 (1974)Google Scholar
  31. Von Voigtlander, P. F., Lorenz, E. G. Trienzenberg, H. J.: Increased sensitivity to dopaminergic agents after chronic neuroletic treatment. J. Pharmacol. Ther. 193, 88–94 (1975)Google Scholar

Copyright information

© Springer-Verlag 1979

Authors and Affiliations

  • A. Hecht
    • 1
  1. 1.Psychopharmacological Research Laboratory, Dept. E.Sct. Hans Mental HospitalRoskildeDenmark

Personalised recommendations